Gus Cairns Editor

Gus joined the editorial team in 2009 and has previously edited HIV Treatment Update and Preventing HIV. He currently focuses on the PrEP in Europe Initiative and on news reporting.

Injectable & long-acting PrEP

Injectable PrEP and COVID show we’re all in this together

UK health services

HIV in the UK 2020: some good news, some less good, but many unknowns

PrEP

PrEP for women in Europe webinars: evaluation form

Injectable & long-acting HIV treatment

First injectable therapy for HIV approved for England and Wales

HIV testing programmes & uptake

HIV testing and prevention services affected badly by COVID in Europe, HIV treatment less so

The search for an HIV prevention vaccine

The search for an HIV prevention vaccine

Clinical trials

Phases of clinical trials

The search for an HIV prevention vaccine

Why is it so difficult to make an HIV prevention vaccine?

The search for an HIV prevention vaccine

Why have we got COVID vaccines but not HIV vaccines?

The search for an HIV prevention vaccine

What is a vaccine?

The search for an HIV prevention vaccine

What’s the latest news on HIV vaccines?

The search for an HIV prevention vaccine

Could an mRNA vaccine protect against HIV?

Injectable & long-acting HIV treatment

Clinics will need new systems to administer injectable HIV therapies, says Canadian early adopter

PrEP programmes & uptake

For long-term PrEP, we need better definitions of adherence, conference hears

Infant feeding

Half of Swiss mothers with HIV decide to breastfeed their baby when given the choice

Transgender people

Half of trans people attending English sexual health clinics took part in PrEP IMPACT study

PrEP programmes & uptake

First efficacy results from England's PrEP IMPACT Trial

Cardiovascular disease

Large US study confirms that people switching from TDF to TAF experience rising blood fat levels